drug · antibody
gocatamig
Phase 2updated 3mo agoby $MRK Merck & Co., Inc.🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 1 2, with 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying gocatamig
- phase2A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- phase2A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- phase2A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 42m ago
Found something off?
comments(0)
5-min edit window · permanent after that